Elongation factor-2 kinase is a critical determinant of the fate and antitumor immunity of CD8(+) T cells.
Das JK, Ren Y, Kumar A, Peng HY, Wang L, Xiong X, Alaniz RC, de Figueiredo P, Ren X, Liu X, et al. Sci Adv. 2022 Feb 4; 8(5):eabl9783. Epub 2022 Feb 2.